We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Gene Associated with Erectile Dysfunction Identified
News

Gene Associated with Erectile Dysfunction Identified

Gene Associated with Erectile Dysfunction Identified
News

Gene Associated with Erectile Dysfunction Identified

Credit: Pixabay
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Gene Associated with Erectile Dysfunction Identified "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

In a new study that ultimately analyzed the genomes of nearly a quarter of a million men, a research team including UC San Francisco scientists has discovered that variants at a single site on Chromosome 6 are associated with a significantly higher risk of developing erectile dysfunction (ED).


The new study – a collaboration between researchers from the lab of UCSF professor Nadav Ahituv, PhD, and researchers at Kaiser Permanente Northern California, the University of Utah and the University of Washington – will be published this week in Proceedings of the National Academies of Sciences.


Although earlier studies of twins have demonstrated that at least a third of ED risk is heritable, until now scientists had never been able to locate a site in the genome that confers this risk.


What brought success this time around was the new study’s massive scale. By analyzing medical records and DNA samples from 36,649 men in the Kaiser Permanente Research Bank’s Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort, the researchers identified a genomic region, or “locus,” associated with ED risk with very high statistical certainty. Then, the scientists confirmed this result in a second study cohort, based on records and DNA from 222,358 men in a large database known as the U.K. Biobank. 


“This significant advance in our understanding of erectile dysfunction is made possible by the unique ability of the Kaiser Permanente Research Bank to link detailed questionnaires, electronic health records, and genetic data on such a large population,” said senior author Stephen Van Den Eeden, PhD, adjunct professor of urology at UCSF and research scientist at Kaiser Permanente Northern California’s Division of Research. 


Both study cohorts were ethnically diverse, including men who identified as white, Latino, African-American and East Asian. The genetic locus on Chromosome 6 was consistently associated with ED risk in all ethnic groups, though the association was not statistically significant in East Asians, likely due to the fact the genetic variant in question appeared infrequently among this group in the cohorts examined in this study.


And importantly, when researchers controlled for other factors known to be associated with ED – body mass index, diabetes, prostate problems, lower urinary tract symptoms, high cholesterol, cardiovascular disease and smoking status – the results remained essentially unchanged, indicating that this genetic locus contains a novel mechanism that is specific to sexual function.


The study revealed a single-nucleotide polymorphism (SNP), a variation in just one “letter” in the genetic code, at a very well-defined site on chromosome 6 that was associated with a significant spike in ED risk – a 26 percent increase in risk for each copy of the variant a person carries. This SNP is not within a gene, but is adjacent to – thought to regulate the activity of – a gene called SIM1, part of a biological pathway that regulates both body weight and sexual function; activating this pathway has previously been shown to be sufficient to induce penile erection.


Given that this is the first study to identify a specific site in the human genome that confers risk of ED, it also points the way to targeted therapies that could be used to treat the 50 percent of men who don’t respond to the ED treatments currently available or experience side effects that cause them to discontinue those treatments.


“This is the first study to find a genetic risk for erectile dysfunction, unveiling potential novel pathways and treatments that can lead to and remedy this condition,” said Ahituv, professor of bioengineering and therapeutic sciences, a “bridge” department of UCSF’s School of Medicine and School of Pharmacy.


The researchers speculate that the findings may also have implications for women, since previous research has shown that the same pathway implicated in the new study also affects sexual desire and arousal in females.

This article has been republished from materials provided by University of California San Francisco. Note: material may have been edited for length and content. For further information, please contact the cited source.

Reference: Jorgenson, E., Matharu, N., Palmer, M. R., Yin, J., Shan, J., Hoffmann, T. J., … Eeden, S. K. V. D. (2018). Genetic variation in the SIM1 locus is associated with erectile dysfunction. Proceedings of the National Academy of Sciences, 201809872. https://doi.org/10.1073/pnas.1809872115

Advertisement